Nadroparin Calcium
- Generic Name
- Nadroparin Calcium
Overview
No overview information available.
Background
No background information available.
Indication
⑴用于预防和治疗血栓栓塞性疾病，特别是预防骨科和普外科手术后的深静脉血栓形成； ⑵在血液透析中预防透析器血凝块形成； ⑶用于不稳定性心绞痛和非ST段抬高心肌梗死急性期的治疗； ⑷用于治疗产科抗磷脂综合征【FDA未批准低分子肝素用于治疗产科抗磷脂综合征；中华医学会围产医学分会，《产科抗磷脂综合征诊断与处理专家共识》（2020）；3.2019年EULAR（欧洲抗风湿病联盟）抗磷脂综合征治疗指南；西班牙风湿病学分会，抗磷脂综合征（2020指南）】。
Associated Conditions
No associated conditions information available.
Clinical Trials
Title | Posted | Study ID | Phase | Status | Sponsor |
|---|
No clinical trials found
No clinical trials found for this drug
FDA Approved Products
Product Name | Manufacturer | Route | Strength | Approved | NDC Code |
|---|
No FDA products found
No FDA products found for this drug
EMA Approved Products
Medicine Name | EMA Number | Auth. Holder | Country | Drug Type | Status | Issued | Opinion | Revision |
|---|
No EMA products found
No EMA products found for this drug
HSA Approved Products
Product Name | Manufacturer | Dosage Form | Strength | Approved | Approval No. |
|---|
No HSA products found
No HSA products found for this drug
NMPA Approved Products
Product Name | Approval No. | Manufacturer | Dosage Form | Trade Name | Strength | Type | Status | Date | Import |
|---|---|---|---|---|---|---|---|---|---|
国药准字H20247012 | 注射剂 | N/A | 0.4ml:4100AXaIU | Chemical Drug | Approved | 2024/03/01 | Domestic | ||
国药准字J20130169 | 注射剂 | N/A | 0.6ml:6150AXaIU | Imported Drug | Approved | N/A | Domestic | ||
国药准字H20223355 | 注射剂 | N/A | 0.4ml:4100 AⅩa IU | Chemical Drug | Approved | 2022/05/31 | Domestic | ||
国药准字H20140347 | 注射剂 | N/A | 0.4ml:4100AXaIU | Chemical Drug | Approved | N/A | Domestic | ||
国药准字H20237142 | 注射剂 | N/A | 0.4ml：4100AXaIU | Chemical Drug | Approved | 2023/11/02 | Domestic | ||
国药准字H20140350 | 注射剂 | N/A | 1.0ml:10250AXaIU | Chemical Drug | Approved | N/A | Domestic | ||
国药准字HJ20181135 | 注射剂 | 速碧林 | 0.3ml:2850AXaIU | Chemical Drug | Approved | 2023/07/24 | Import | ||
国药准字H20223356 | 注射剂 | N/A | 0.6ml:6150 AⅩa IU | Chemical Drug | Approved | 2022/05/31 | Domestic | ||
国药准字H20140352 | 注射剂 | N/A | 0.4ml:4100AXaIU | Chemical Drug | Approved | N/A | Domestic | ||
国药准字HJ20181137 | 注射剂 | 速碧林 | 0.6ml:5700AXaIU | Chemical Drug | Approved | 2023/06/29 | Import |
PPB Approved Products
Product Name | Registration Code | Company | Category | Sale Type | Reg. Date |
|---|
No PPB products found
No PPB products found for this drug
TGA Approved Products
Product Name | ARTG ID | Sponsor | Status | Reg. Date | Ingredient |
|---|
No TGA products found
No TGA products found for this drug
© Copyright 2025. All Rights Reserved by MedPath